In December 2025, the Department of Health and Social Care (DHSC) announced that it will be introducing Category H to Part VIIIA of the Drug Tariff from March 2026. Certain products available from multiple suppliers in Category C will begin to move to Category H in a phased approach. This change, being imposed by DHSC,
Read moreMHRA Class 2 Medicines Recall: Baclofen 10mg/5ml Oral Solution (Syri Limited, T/A SyriMed) Drug alert number: EL(26)A/06 Date issued: 3 February 2026 Syri Limited, T/A SyriMed is recalling batches of product as a precautionary measure due to crystallisation observed over time in the oral solution. DMRC reference number: DMRC-38317957 Company name:Syri Limited, T/A SyriMed Medicine Details
Read moreMHRA Class 2 Medicines Recall: Carmustine 100mg powder and solvent for concentrate for solution for infusion (Accord Healthcare Ltd) Drug alert number: EL(26)A/05 Date issued: 2 February 2026 Accord Healthcare limited is recalling a single batch due to an out of specification test result. DMRC reference number: DMRC-38091819 Company name: Accord Healthcare Ltd Medicine Details Carmustine
Read moreCommunity Pharmacy England on behalf of pharmacy owners made further applications to the Department of Health and Social Care (DHSC) and the NHS Business Services Authority (NHSBSA), resulting in a further 11 new products being added to the ‘Drugs for which Discount is Not Deducted’ (DND) list from 1 February 2026. This takes the total
Read moreThe Department of Health and Social Care (DHSC) has today (30/01/2026) confirmed the following list of price concessions for January 2026: This list includes three improved prices following representations made by Community Pharmacy England on behalf of community pharmacy owners. Please note: Community Pharmacy England has submitted price concession applications for a number of other medicines
Read moreFollowing representations from Community Pharmacy England, the Department of Health and Social Care (DHSC) has re-determined that the following products will be granted special container status from 1 February 2026. Generic drug name (dm+d descriptor) Brand and/or manufacturer Pack Size Special container Relugolix 120mg tablets Orgovyx® 120mg tablets (Accord-UK Ltd) 30 tablet Complete pack Salbutamol 2.5mg/2.5ml
Read moreCommunity pharmacy teams are advised that, from 1 February 2026, the NHS Business Services Authority (NHSBSA) will no longer accept end‑of‑month prescription batch submissions at its Bridge House office. Pharmacy teams should despatch their January 2026 bundle to the new address below. ‘NHSBSA has confirmed that, from this date, all batches must be sent to
Read moreThe Medicines and Healthcare products Regulatory Agency (MHRA) has issued a Drug Safety Alert regarding Glucagon-Like Peptide-1 (GLP-1) receptor agonists and dual GLP-1/glucose-dependent insulinotropic polypeptide (GIP) receptor agonists. The product information for all GLP-1 receptor agonists and dual GLP-1/GIP receptor agonists (dulaglutide, exenatide, liraglutide, semaglutide and tirzepatide) has been further updated to highlight the potential
Read moreEaststone Limited is initiating a recall of all batches of quetiapine oral suspension products due to a potential risk of overdose, which could have consequences for the safety of patients. This alert is for action by: primary and secondary care, specifically those involved in pharmacy services, including dispensing general practices and those involved in the prescribing for mental health conditions. This is
Read moreThe Department of Health and Social Care (DHSC) has today (29/01/2026) confirmed the following list of price concessions for January 2026: Drug Pack size Price concession Aspirin 75mg tablets 28 £2.95 Chloramphenicol 0.5% eye drops 10 £2.75 Cimetidine 400mg tablets 60 £5.58 Co-codamol 30mg/500mg capsules 100 £5.68 Diclofenac sodium 50mg gastro-resistant tablets 28 £6.86 Glycerol
Read more
